Unichem receives ANDA approval for quetiapine extended-release tablets
Quetiapine Extended-Release Tablets are indicated for the treatment of Schizophrenia, Bipolar disorder and adjunctive treatment of Major Depressive Disorder (MDD)
Quetiapine Extended-Release Tablets are indicated for the treatment of Schizophrenia, Bipolar disorder and adjunctive treatment of Major Depressive Disorder (MDD)
The domestic business has registered a single-digit growth on the huge base of last year and this was driven by robust demand across established therapies and brands
Strides is the first Indian company to get approval for the product.
Bisoprolol Fumarate Tablets are used to treat high blood pressure.
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
Mittal will be driving expansion of the provider network across India
Granite Bio's lead candidate is a novel monoclonal antibody for treatment of autoimmune and certain cancer indications. B
Lacosamide Injection is used to treat partial-onset seizures.
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
Subscribe To Our Newsletter & Stay Updated